Clinical trials: Noncardioembolic Cerebral Infarction

Noncardioembolic Cerebral Infarction

Cilostazol Stroke Prevention Study for Antiplatelet Combination

• Completed
• Age: 20 to 85 years
• Phase 4

To examine the efficacy and safety of dual antiplatelet therapy (DAPT) including cilostazol (Pletaal OD Tablet ®) in comparison with antiplatelet monotherapy (excluding cilostazol) for secondary prevention of ischemic stroke in…

Trial name

CSPS・com (NCT01995370)

Testing

aspirin, clopidogrel, cilostazol

Where

Japan

Volunteers

1,884 people

Sponsor

Japan Cardiovascular Research Foundation